Correlation of therapeutic effect of obidoxime and dosing time in the acute intoxication by chlorfenvinphos in rats

Basic and Clinical Pharmacology and Toxicology

Volumn 105, Issue 1, 2009, Pages 37-45

  Raszewski, Grzegorz ^a,b   Filip, Rafaå ^b  

^a Department of Pathophysiology ^*  (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ATROPINE; CLOFENVINFOS; DIAZEPAM; OBIDOXIME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; COLORIMETRY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME REACTIVATION; INTOXICATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; TISSUE;

ACETYLCHOLINESTERASE; ANIMALS; ANTICONVULSANTS; ANTIDOTES; ATROPINE; BRAIN; CHLORFENVINPHOS; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; DIAPHRAGM; DIAZEPAM; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; INTERCOSTAL MUSCLES; MALE; MEDULLA OBLONGATA; OBIDOXIME CHLORIDE; RANDOM ALLOCATION; RATS; RATS, WISTAR; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 67651233808     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2009.00398.x     Document Type: Article

References (46)

1. Eddleston M, Buckley NA, Eyer P, Dawson AH. Medical management of acute organophosphorus pesticide self-poisoning. Lancet 2008 371 : 597 607. (Pubitemid 351232010)
2. Eddleston M, Eyer P, Worek F, Mohamed F, Senarathna L, Mayer L et al. Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet 2005 366 : 1452 9.
3. Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol Rev 2003 22 : 165 90.
4. Johanson MK, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, Ligtenstein DA et al. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg Med 2000 70 : 22 37. (Pubitemid 30321724)
5. Raszewski G, Filip R. Use of oximes in the therapy of acute intoxication by organophosphorus compounds. Przegl Lek 2004 61 : 181 4.
6. Marrs TC, Rice P, Vale JA. The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Toxicol Rev 2006 25 : 297 323.
7. Antonijevic B, Stojiljkovic MP. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Clin Med Res 2007 1 : 71 82. (Pubitemid 350218782)
8. Eyer P, Szinicz L, Thiermann H, Worek F, Zilker T. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality. Toxicology 2007 233 : 108 19.
9. Kuca K, Cabal J, Jun D, Hrabinova M. Potency of five structurally different acetylcholinesterase reactivators to reactivate human brain cholinesterases inhibited by cyclosarin. Clin Toxicol 2007 45 : 512 5.
10. Worek F, Bäcker M, Thiermann H, Szinicz L, Mast U, Klimmek R et al. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum Exp Toxicol 1997 16 : 466 72.
11. Ellman GL, Courtney KD, Andres V. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961 7 : 88 95.
12. Kassa J, Humlicek V. A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice. Drug Chem Toxicol 2008 31 : 127 35.
13. Kassa J, Karasova J, Musilek K, Kuca K. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Toxicology 2008 43 : 311 6.
14. Worek F, Aurbek N, Koller M, Becker C, Eyer P, Thierman H. Kinetic analysis of reactivation and aging of human acetylcholinesterase inhibited by different phosphoramidates. Biochem Pharmacol 2007 73 : 1807 17.
15. Li B, Stribley JA, Ticu A, Xie W, Schopfer LM, Hammond P et al. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J Neurochem 2000 75 : 1320 31.
16. Worek F, Thierman H, Sinicz L, Eyer P. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem Pharmacol 2004 68 : 2237 48.
17. Bajgar J, Kuca K, Jun D, Bartosova L, Fusek J. Cholinesterase reactivators: the fate and effects in the organism poisoned with organophosphates/nerve agents. Curr Drug Metab 2007 8 : 803 9.
18. John M, Oommen A, Zachariah A. Muscle injury in organophosphorous poisoning and its role in the development of intermediate syndrome. Neurotoxicology 2003 24 : 43 53. (Pubitemid 36091160)
19. Besser R, Weilemann LS, Gutman L. Efficiacy of obidoxime in human organophosphorus poisoning: determination by neuromuscular transmission studies. Muscle Nerve 1995 18 : 15 22.
20. Hoffmann U, Papendorf T. Organophosphate poisonings with parathion and dimethoate. Intensive Care Med 2006 32 : 464 8.
21. Petroianu GA, Arafat K, Kuca K, Kassa J. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro. J Appl Toxicol 2006 26 : 64 71.
22. Jokanović M, Maksimović M. A comparison of trimedoxim, obidoxime and HI-6 in the treatment of oral organophosphorus insecticide poisoning in the rat. Arch Toxicol 1995 70 : 119 23.
23. Antonijevic B, Bokonjic D, Stojiljkovic MP, Klilibarda V, Milovanovi ZA, Nedeljkovi M et al. Efficacy of trimedoxime in mice poisoned with dichlorvos, heptenophos or monocrotophos. Basic Clin Pharmacol Toxicol 2005 96 : 111 7.
24. Van Helden HPM, Busker RW, Melchers BPC, Bruijnzeel PLB. Pharmacological effects of oximes: how relevant are they? Arch Toxicol 1996 70 : 779 86.
25. Kalász H, Hasan MY, Sheen R, Kuca K, Petroianu G, Lundanyi K et al. HPLC analysis of K-48 concentration in plasma. Anal Bioanal Chem 2006 385 : 1062 7.
26. Tekes K, Hasan MY, Sheen R, Kuca K, Petroianu G, Lundanyi K et al. High-performance liquid chromatographic determination of the plasma concentration of K-27, a novel oxime-type cholinesterase reactivator. Chromatogr A 2006 1122 : 84 7.
27. Raszewski G, Burda R. Obidoxime content in the brain tissue of rats intoxicated with organophosphate insecticide - 'Chlorfenvinphos', after administration of oxime. Acta Toxicologica 2006 14 : 31 35. (Pubitemid 46917076)
28. Van Helden HPM, van der Wiel HJ, Zijlstra JJ, Melchers BPC, Busker RW. Comparison of the therapeutic effects and pharmacokinetics of HI-6, HLö-7, HGG-12, HGG-42 and obidoxime following non-reactivatable acetylcholinesterase inhibition in rats. Arch Toxicol 1994 68 : 224 30.
29. Lorke DE, Kalasz H, Petroianu GA, Tekes K. Entry of oximes into the brain: a review. Curr Med Chen 2008 15 : 743 53.
30. Okuno S, Sakurada K, Ohta H, Ikegaya H, Kazui Y, Akutsu T et al. Blood-brain barrier penetration of novel pyridinealdoxime methiodide (PAM)-type oximes examined by brain microdialysis with LC-MS/MS. Toxicol Appl Pharmacol 2008 227 : 8 15. (Pubitemid 351187945)
31. Kido Y, Tamai I, Ohnari A, Sai Y, Kagami T, Nezu J et al. Functional relevance of carnitine transporter OCTN2 to brain distribution of l-carnitine and acetyl-l-carnitine across the blood-brain barrier. J Neurochem 2001 9 : 959 69.
32. Sung JH, Yu KH, Park JS, Tsuruo T, Kim DD, Shim CK et al. Saturable distribution of tacrine into the striatal extracellular fluid of the rat: evidence of involvement of multiple organic cation transporters in the transport. Drug Metab Dispos 2005 33 : 440 8.
33. Sakurada K, Matsubara K, Shimizu K, Shiono H, Seto Y, Tsuge K et al. 2003 Pralidoxime iodide (2-PAM) penetrates across the blood-brain barrier. Neurochem Res 2003 28 : 1401 7.
34. Lorke DE, Hasan MY, Nurulain SM, Sheen R, Kuca K, Petroianu GA. Entry of two new asymmetric bispyridinium oximes (K-27 and K-48) into the rat brain: comparison with obidoxime. J Appl Toxicol 2007 27 : 482 90.
35. Petroianu GA, Lorke DE, Hasan MY, Adem A, Sheen R, Nurulain SM et al. Paraoxon has only a minimal effect on pralidoxime brain concentration in rats. J Appl Toxicol 2007 27 : 350 7.
36. Lorke DE, Nurulain SM, Hasan MY, Kuca K, Musilek K, Petroianu GA. Eight new bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: in vivo efficacy to protect from diisopropylfluorophosphate toxicity. J Appl Toxicol 2008 28 : 920 8.
37. Worek F, Thiermann H, Szinicz L. Reactivation and aging kinetics of human acetylcholinesterase inhibited by organophosphonylcholines. Arch Toxicol 2004 78 : 212 7.
38. Ashani Y, Bhattacharjee AK, Leader H, Saxena A, Doctor BP. Inhibition of cholinesterases with cationic phosphonyl oximes highlights distinctive properties of the charged pyridine groups of quaternary oxime reactivators. Biochem Pharmacol 2003 66 : 191 202. (Pubitemid 36776393)
39. Kiderlen D, Worek F, Klimmek R, Eyer P. The phosphoryl oxime-destroying activity of human plasma. Arch Toxicol 2000 74 : 27 32. (Pubitemid 30207534)
40. Kanard K. The acute treatment of nerve agent exposure. J Neurol Sci 2006 249 : 86 94.
41. Tayyse L, Daulon S, Delamanche S, Bellier B, Breton P. Protection against soman-induced neuropathology and respiratory failure: a comparison of the efficacy of diazepam and avizafone in guinea pig. Toxicology 2006 225 : 25 35.
42. Maxwell DM, Brecht KM, Chang FC, Koplovitz I, Shih TM, Sweeney RE. Toxicodynamic modeling of highly toxic organophosphorus compounds. J Mol Neurosci 2006 30 : 129 31.
43. Stefanovic D, Antonijevic B, Bokonjic D, Stojiljkovic MP, Milovanovic ZA, Nedeljkovic M et al. Effect of sodium bicarbonate in rats acutely poisoned with dichlorvos. Basic Clin Pharmacol Toxicol 2006 98 : 173 80.
44. Harrison PK, Sheridan RD, Green AC, Scott IR, Tattersal JE. A guinea pig hippocampal slice model of organophosphate-induced seizure activity. J Pharmacol Exp Ther 2004 310 : 678 86.
45. Johnson DD, Wilcox WC. Studies on the mechanism of the protective and antidotal actions of diazepam in organophosphate poisoning. Eur J Pharmacol 1975 34 : 127 32.
46. Marrs TC. The role of diazepam in the treatment of nerve agent poisoning in a civilian population. Toxicol Rev 2004 23 : 145 57.